Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Other Non Operating Income (2021 - 2025)

Senti Biosciences has reported Other Non Operating Income over the past 5 years, most recently at $200000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 2.91% year-over-year to $200000.0; the TTM value through Dec 2025 reached $801000.0, up 298.51%, while the annual FY2025 figure was $800000.0, 300.0% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $200000.0 at Senti Biosciences, down from $223000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $1.3 million in Q4 2022 and troughed at -$54000.0 in Q1 2022.
  • A 5-year average of $133529.4 and a median of $6000.0 in 2024 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: surged 13270.0% in 2022 and later tumbled 800.0% in 2023.
  • Year by year, Other Non Operating Income stood at -$10000.0 in 2021, then surged by 13270.0% to $1.3 million in 2022, then crashed by 100.53% to -$7000.0 in 2023, then surged by 3042.86% to $206000.0 in 2024, then decreased by 2.91% to $200000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for SNTI at $200000.0 in Q4 2025, $223000.0 in Q3 2025, and $200000.0 in Q2 2025.